Research ArticleConference Report
Knowledge Management and ICH
Stephan Rönninger
PDA Journal of Pharmaceutical Science and Technology March 2015, 69 (2) 326-332; DOI: https://doi.org/10.5731/pdajpst.2015.01049
Stephan Rönninger
*Amgen (Europe) GmbH, Zug, ZG, Switzerland

References
- 1.↵
ICH Q10. Pharmaceutical quality systems. ICH, June 2008.
- 2.↵
ICH Q9. Quality Risk Management. ICH, November 2005.
- 3.↵
Q-IWG Q&A. Quality Implementation Working Group on Q8, Q9 and Q10, Questions & Answers (R4). ICH, November 2010.
- 4.↵
ICH Q8, Pharmaceutical Development. ICH, August 2009 [including Part I: ‘Pharmaceutical Development’, November 10 2006 and Part II: ‘Annex to Pharmaceutical Development’, ICH Q8 (R2)], November 2008, and ICH Q11, Develop and Manufacture of Drug Substance (Chemical Entities and Biotechnological/Biological Entities), May 2012.
- 5.↵
Training Programme for Q8/Q9/Q10. ICH Quality Implementation Working Group (Q-IWG), November 2010.
- 6.↵
ICH-Endorsed Guide for ICH Q8/Q9/Q10 Implementation. ICH, Point to Consider (R2), December 2011.
- 7.↵
- Flexman G.,
- Husovich M.,
- Orloff J.,
- Patel J.,
- Roenninger S.,
- Skoog M.,
- Torbeck L.,
- Weese D.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 69, Issue 2
March/April 2015
Knowledge Management and ICH
Stephan Rönninger
PDA Journal of Pharmaceutical Science and Technology Mar 2015, 69 (2) 326-332; DOI: 10.5731/pdajpst.2015.01049
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.